Abstract:Gastric cancer (GC) is the fifth most commonly diagnosed malignant disease and the third leading cause of cancer‑related deaths worldwide. Recently, numerous microRNAs (miRNAs) have been determined to contribute to GC initiation and progression, suggesting that miRNAs may be developed as effective diagnostic and prognostic molecular biomarkers and can be investigated as therapeutic targets for patients with this disease. Therefore, further investigation of the miRNAs involved in GC development represents an opportunity to improve the prognosis of GC patients. miRNA‑454 (miR‑454) is abnormally expressed in multiple types of human cancer. However, the expression pattern, biological roles and underlying mechanism of miR‑454 in GC remain unclear and require further investigation. In the present study, we assessed miR‑454 expression in GC tissues and cell lines. We also explored the effects of miR‑454 on the biological behaviours of tumour cells and the underlying molecular mechanisms of miR‑454. The results revealed that miR‑454 was significantly downregulated in GC tissues and cell lines. Low miR‑454 expression was positively associated with lymph node metastasis, invasive depth and TNM stage. Additionally, upregulation of miR‑454 inhibited cell proliferation and invasion and induced the apoptosis of the GC cells. Subsequently, mitogen‑activated protein kinase 1 (MAPK1) was identified as a direct target of miR‑454. MAPK1 was upregulated in GC tissues and was found to be negatively correlated with the miR‑454 expression level. Downregulation of MAPK1 also suppressed GC cell proliferation and invasion and increased apoptosis, thereby resembling the suppressive effects of miR‑454 overexpression in GC. Moreover, upregulation of MAPK1 reversed the tumour‑suppressive effects of miR‑454 in GC. Collectively, our data demonstrated that miR‑454 may play tumour‑suppressing roles in GC through the regulation of MAPK1, suggesting that miR‑454 may be a novel biomarker and therapeutic target for patients with this disease.

Mir-644A Inhibits Cellular Proliferation and Invasion Via Suppression of CtBP1 in Gastric Cancer Cells

Retracted: Mir‐944 Inhibits Metastasis of Gastric Cancer by Preventing the Epithelial–mesenchymal Transition Via MACC1/Met/AKT Signaling

Restoration Of Mir-1228*Expression Suppresses Epithelial-Mesenchymal Transition In Gastric Cancer

Mir-338-3p Functions As a Tumor Suppressor in Gastric Cancer by Targeting PTP1B

Mir-129-5p Attenuates Cell Proliferation and Epithelial Mesenchymal Transition Via HMGB1 in Gastric Cancer

Mir-211 Inhibits Cell Epithelial-Mesenchymal Transition by Targeting Mmp9 in Gastric Cancer

Mir-301a-5p/Scin Promotes Gastric Cancer Progression Via Regulating Stat3 And Nf-Kappa B Signaling

Mir-345 Inhibits Migration and Stem-Like Cell Phenotype in Gastric Cancer Via Inactivation of Rac1 by Targeting EPS8

Mir-1273H-5p Suppresses the Penetration and Pervasion of Gastric Cancer Cells Via Suppressing CXCL12 Expression

MicroRNA Library-Based Functional Screening Identified Mir-137 As a Suppresser of Gastric Cancer Cell Proliferation

Mir-204-5p Suppress Lymph Node Metastasis Via Regulating CXCL12 and CXCR4 in Gastric Cancer

Mir-188-5p Emerges As an Oncomirna to Promote Gastric Cancer Cell Proliferation and Migration Via Upregulation of SALL4

MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer

Mirna-451 Inhibits Proliferation and Motility of the Gastric Cancer SGC-7901 Cell Line Via Targeting AKT-mediated Signal Pathway

Mir-885-5p Inhibits Invasion and Metastasis in Gastric Cancer by Targeting Malic Enzyme 1

MiR-124-5p Inhibits the Progression of Gastric Cancer by Targeting MIEN1.

MicroRNA-449a Inhibits Proliferation and Induces Apoptosis by Directly Repressing E2F3 in Gastric Cancer

Mir-638 Suppresses Cell Proliferation in Gastric Cancer by Targeting Sp2.

MicroRNA-454 Inhibits the Malignant Biological Behaviours of Gastric Cancer Cells by Directly Targeting Mitogen-Activated Protein Kinase 1

MiR-140-3p Impedes Gastric Cancer Progression and Metastasis by Regulating BCL2/BECN1-Mediated Autophagy

Mir-215 Promotes Cell Migration and Invasion of Gastric Cancer by Targeting Retinoblastoma Tumor Suppressor Gene 1.